324 related articles for article (PubMed ID: 8816482)
1. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
Luo G; Yu-Lee L
J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
4. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.
Gouilleux F; Pallard C; Dusanter-Fourt I; Wakao H; Haldosen LA; Norstedt G; Levy D; Groner B
EMBO J; 1995 May; 14(9):2005-13. PubMed ID: 7744007
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.
Kazansky AV; Kabotyanski EB; Wyszomierski SL; Mancini MA; Rosen JM
J Biol Chem; 1999 Aug; 274(32):22484-92. PubMed ID: 10428824
[TBL] [Abstract][Full Text] [Related]
6. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
7. NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the alpha-helical region of the STAT5 transactivation domain.
Litterst CM; Kliem S; Marilley D; Pfitzner E
J Biol Chem; 2003 Nov; 278(46):45340-51. PubMed ID: 12954634
[TBL] [Abstract][Full Text] [Related]
8. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
Verdier F; Rabionet R; Gouilleux F; Beisenherz-Huss C; Varlet P; Muller O; Mayeux P; Lacombe C; Gisselbrecht S; Chretien S
Mol Cell Biol; 1998 Oct; 18(10):5852-60. PubMed ID: 9742102
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobic residues Phe751 and Leu753 are essential for STAT5 transcriptional activity.
Callus BA; Mathey-Prevot B
J Biol Chem; 2000 Jun; 275(22):16954-62. PubMed ID: 10748177
[TBL] [Abstract][Full Text] [Related]
10. Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells.
Yamashita H; Xu J; Erwin RA; Farrar WL; Kirken RA; Rui H
J Biol Chem; 1998 Nov; 273(46):30218-24. PubMed ID: 9804779
[TBL] [Abstract][Full Text] [Related]
11. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
Aoki N; Matsuda T
J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
[TBL] [Abstract][Full Text] [Related]
12. Naturally occurring dominant negative variants of Stat5.
Wang D; Stravopodis D; Teglund S; Kitazawa J; Ihle JN
Mol Cell Biol; 1996 Nov; 16(11):6141-8. PubMed ID: 8887644
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of STAT5 by a point mutation in the SH2 domain.
Ariyoshi K; Nosaka T; Yamada K; Onishi M; Oka Y; Miyajima A; Kitamura T
J Biol Chem; 2000 Aug; 275(32):24407-13. PubMed ID: 10823841
[TBL] [Abstract][Full Text] [Related]
14. Lactogenic hormone activation of Stat5 and transcription of the beta-casein gene in mammary epithelial cells is independent of p42 ERK2 mitogen-activated protein kinase activity.
Wartmann M; Cella N; Hofer P; Groner B; Liu X; Hennighausen L; Hynes NE
J Biol Chem; 1996 Dec; 271(50):31863-8. PubMed ID: 8943229
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mammary gland factor/Stat5a during mammary gland development.
Kazansky AV; Raught B; Lindsey SM; Wang YF; Rosen JM
Mol Endocrinol; 1995 Nov; 9(11):1598-609. PubMed ID: 8584036
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities.
Boucheron C; Dumon S; Santos SC; Moriggl R; Hennighausen L; Gisselbrecht S; Gouilleux F
J Biol Chem; 1998 Dec; 273(51):33936-41. PubMed ID: 9852045
[TBL] [Abstract][Full Text] [Related]
17. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
Liu X; Robinson GW; Gouilleux F; Groner B; Hennighausen L
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8831-5. PubMed ID: 7568026
[TBL] [Abstract][Full Text] [Related]
18. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation.
Ilaria RL; Hawley RG; Van Etten RA
Blood; 1999 Jun; 93(12):4154-66. PubMed ID: 10361113
[TBL] [Abstract][Full Text] [Related]
19. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation.
Liu X; Robinson GW; Hennighausen L
Mol Endocrinol; 1996 Dec; 10(12):1496-506. PubMed ID: 8961260
[TBL] [Abstract][Full Text] [Related]
20. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.
Chughtai N; Schimchowitsch S; Lebrun JJ; Ali S
J Biol Chem; 2002 Aug; 277(34):31107-14. PubMed ID: 12060651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
